HQH (abrdn Healthcare Investors) ROE % Adjusted to Book Value: 15.98% (As of Mar. 2026)


HQH abrdn Healthcare Investors HQH
40 GF Score
Price $22.00
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors ROE % Adjusted to Book Value?

abrdn Healthcare Investors HQH +1.24% 40 ROE % Adjusted to Book Value is 15.98% as of Mar. 2026. GuruFocus rates HQH with a GF Score™ of 40/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review.

abrdn Healthcare Investors's ROE % for the quarter that ended in Mar. 2026 was 14.22%. abrdn Healthcare Investors's PB Ratio for the quarter that ended in Mar. 2026 was 0.89. abrdn Healthcare Investors's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 15.98%.


abrdn Healthcare Investors ROE % Adjusted to Book Value Related Terms


abrdn Healthcare Investors ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for abrdn Healthcare Investors's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Healthcare Investors ROE % Adjusted to Book Value Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only 14.03 -21.04 7.35 20.20 9.74

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.20 17.92 -16.18 36.10 15.98

HQH vs DSL, NMZ, JFR: ROE % Adjusted to Book Value Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors ROE % Adjusted to Book Value vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's ROE % Adjusted to Book Value falls into.


HQH
40GF Score
abrdn Healthcare Investors HQH
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

abrdn Healthcare Investors ROE % Adjusted to Book Value Calculation

abrdn Healthcare Investors's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.16% / 0.94
=9.74%

abrdn Healthcare Investors's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=14.22% / 0.89
=15.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 15.98% mean?
abrdn Healthcare Investors (HQH) has a ROE % Adjusted to Book Value of 15.98% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on abrdn Healthcare Investors and its competitors.
Is abrdn Healthcare Investors' ROE % Adjusted to Book Value too high?
abrdn Healthcare Investors' current ROE % Adjusted to Book Value is 15.98%. Overall, abrdn Healthcare Investors has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' ROE % Adjusted to Book Value compare to DSL and NMZ?
abrdn Healthcare Investors' ROE % Adjusted to Book Value of 15.98% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Asset Management company?
A good ROE % Adjusted to Book Value depends on the Asset Management industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on abrdn Healthcare Investors and its competitors. abrdn Healthcare Investors's current ROE % Adjusted to Book Value is 15.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $22.00 — trading 56.2% below its estimated fair value. The current ROE % Adjusted to Book Value is 15.98%. abrdn Healthcare Investors' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current ROE % Adjusted to Book Value is 15.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $22.00 is trading 56.2% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • ROE % Adjusted to Book Value: 15.98%
  • GF Value™: $50.26 vs. price of $22.00 (56.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
40GF Score

Get the complete analysis for HQH

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price
$50.26
GF Value